Nosocomial or healthcare facility-related pneumonia in adults

被引：2

作者：

Balaguera H.U. ^{[1
]}

Mir J. ^{[1
]}

Craven D.E. ^{[1
]}

机构：

[1] Section of Infectious Diseases, Boston Medical Center, Dowling Building 3 North, One Boston Medical Center Place, Boston, 02118, MA

来源：

Current Infectious Disease Reports | 2000年 / 2卷 / 3期

关键词：

Clinical Pulmonary Infection Score; Infect Control Hosp; Intensive Care Unit Patient; Nosocomial Pneumonia; Respir Crit;

D O I：

10.1007/s11908-000-0038-4

中图分类号：

学科分类号：

摘要：

Nosocomial or hospital-acquired pneumonia (HAP) is a dynamic disease with multiple etiologic agents and a changing natural history. The emergence and spread of multidrug-resistant bacterial pathogens is a current concern. Because of the parallels between HAP and pneumonia occurring in patients in subacute or chronic care facilities, we suggest the use of a more inclusive term for these patients: healthcare facility-related pneumonia. This article focuses on current controversies in the pathogenesis, diagnosis, management, and prevention of bacterial HAP in adults. We endorse early, appropriate antibiotic therapy based on disease severity and the use of strategies to prevent infection, improve patient outcome, and reduce hospital costs. © 2000, Current Science Inc.

引用

页码：215 / 223

页数：8

共 47 条

[1]

Craven D.E., Steger K.A., LaForce F.M., Pneumonia, Hospital Infections, pp. 487-513, (1997)

[2]

Vincent J.-L., Bihari D.J., Suter P.M., Et al., The prevalence of nosocomial infection in intensive care units in Europe: results of the European prevalence of infection in intensive care (EPIC) study, JAMA, 274, pp. 639-644, (1995)

[3]

Kollef M.H., The prevention of ventilator-associated pneumonia, N Engl J Med, 340, pp. 627-634, (1999)

[4]

Tablan O.C., Anderson L.J., Arden N.H., Et al., Guideline for prevention of nosocomial pneumonia: Part I. Issues on prevention of nosocomial pneumonia, 1994, Infect Control Hosp Epidemiol, 15, pp. 588-625, (1994)

[5]

Montecalvo M.A., Jarvis W.R., Uman J., Et al., Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting, Ann Intern Med, 131, pp. 269-272, (1999)

[6]

Smith T.L., Pearson M.L., Wilcox K.R., Et al., Emergence of vancomycin resistance in Staphylococcus aureus, N Engl J Med, 340, pp. 493-501, (1999)

[7]

Pallares R., Linares J., Vadillo M., Et al., Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain, N Engl J Med, 333, pp. 474-480, (1995)

[8]

Villers D., Espaze E., Coste-Burel M., Et al., Nosocomial Acinetobacter baumanii infections: microbiological and clinical epidemiology, Ann Intern Med, 129, pp. 182-189, (1998)

[9]

Weber D.J., Rasch R., Rutala W.A., Nosocomial infections in the ICU, Chest, 115, pp. 34S-41S, (1999)

[10]

Thompson R.S., Hall N.K., Szpiech M., Hospitalization and mortality rates for nursing home-acquired pneumonia, J Fam Pract, 48, pp. 291-293, (1999)

← 1 2 3 4 5 →